Authors' reply to: Anti‐Müllerian hormone and breast cancer risk: is the correlation possibly associated with PCOS
Date
2019Journal
International Journal of CancerPublisher
Wiley-Liss Inc.Type
article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055725820&doi=10.1002%2fijc.31728&partnerID=40&md5=1c1a97e46cdf8a889befab1542797e3c; http://hdl.handle.net/10713/10190ae974a485f413a2113503eed53cd6c53
10.1002/ijc.31728
Scopus Count
Collections
Related articles
- Anti-Mullerian hormone and breast cancer risk-is the correlation possibly associated with the PCOS?
- Authors: Blumenfeld Z
- Issue date: 2019 Jan 1
- [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
- Authors: Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H
- Issue date: 2014
- Antimüllerian hormone and polycystic ovary syndrome.
- Authors: Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, Hsu MI
- Issue date: 2011 Jul
- Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
- Authors: Lie Fong S, Laven JSE, Duhamel A, Dewailly D
- Issue date: 2017 Aug 1
- Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
- Authors: Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D
- Issue date: 2017 Aug 1